Results 21 to 30 of about 100,852 (314)

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

open access: yesClinical Infectious Diseases, 2016
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to
T. Patterson   +16 more
semanticscholar   +1 more source

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

open access: yesNew England Journal of Medicine, 2002
BACKGROUND Voriconazole is a broad-spectrum triazole that is active against aspergillus species. We conducted a randomized trial to compare voriconazole with amphotericin B for primary therapy of invasive aspergillosis.
R. Herbrecht   +21 more
semanticscholar   +1 more source

Aspergillosis

open access: yesDefinitions, 2020
Aspergillosis is a rare infectious disease caused by inhalation of the opportunistic fungus aspergillus that can lead to the following manifestations: allergic bronchopulmonary aspergillosis (ABPA), aspergilloma, chronic necrotizing pulmonary ...

semanticscholar   +1 more source

Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis

open access: yesMycoses (Berlin), 2021
COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported worldwide. However, basic epidemiological characteristics have not been well established.
H. Mitaka   +3 more
semanticscholar   +1 more source

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature

open access: yesJournal of Fungi, 2018
Many chronic lung diseases are characterized by the hypersecretion of mucus. In these conditions, the administration of mucoactive agents is often indicated as adjuvant therapy. N-acetylcysteine (NAC) is a typical example of a mucolytic agent.
Akaninyene Otu   +2 more
doaj   +1 more source

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. [PDF]

open access: yes, 2017
Purpose of reviewDiagnosis during early stages of invasive aspergillosis (IA) and targeted antifungal treatment has the potential to improve survival significantly.
Heldt, Sven, Hoenigl, Martin
core   +1 more source

A MIQE-Compliant Real-Time PCR Assay for Aspergillus Detection [PDF]

open access: yes, 2012
PMCID: PMC3393739This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
AH Groll   +46 more
core   +6 more sources

A hemophagocytic lymphohistiocytosis case with newly defined UNC13D (C.175G>C; p.Ala59Pro) mutation and a rare complication [PDF]

open access: yes, 2015
Hemophagocytic lymphohistiocytosis (HLH) represents a severe hyperinflammatory condition with cardinal symptoms of prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages with impaired ...
Akpınar, Funda Özgürler   +7 more
core   +2 more sources

Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches

open access: yesMycoses (Berlin), 2021
Invasive aspergillosis (IA) is an increasingly recognised phenomenon in critically ill patients in the intensive care unit, including in patients with severe influenza and severe coronavirus disease 2019 (COVID‐19) infection.
J. Jenks, H. Nam, M. Hoenigl
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy